VNRX – volitionrx limited (US:AMEX)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

VNRX

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/18

08:05 am

vnrx

VolitionRx (NYSE:VNRX) had its price target lowered by analysts at D. Boral Capital from $5.00 to $3.00. They now have a "buy" rating on the stock.

Low Report

VolitionRx (NYSE:VNRX) had its price target lowered by analysts at D. Boral Capital from $5.00 to $3.00. They now have a "buy" rating on the stock.

Report

12/17

08:45 am

vnrx

Volition Issues Business Review 2025

Low Report

Volition Issues Business Review 2025

Report

12/11

09:00 am

vnrx

Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment

Low Report

Volition Solves Liquid Biopsy's "Needle in a Haystack" Problem; Achieves 180-fold (18,000%) Enrichment

Report

12/8

09:00 am

vnrx

Volition Announces Two Abstracts were Presented at the North America Conference on Lung Cancer

Low Report

Volition Announces Two Abstracts were Presented at the North America Conference on Lung Cancer

Report

12/4

01:28 pm

vnrx

VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.

Low Report

VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.

Report

12/4

09:00 am

vnrx

VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis

Medium Report

VolitionRx Limited Announces Inclusion of its Nu.Q® NETs Assay as Innovative Biomarker in France's Real-World Evaluation of Early Detection of Sepsis

Report

12/3

02:19 pm

vnrx

VolitionRx (NYSE:VNRX) had its "hold" rating reaffirmed by analysts at Maxim Group.

Low Report

VolitionRx (NYSE:VNRX) had its "hold" rating reaffirmed by analysts at Maxim Group.

Report

11/26

12:56 pm

vnrx

VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.

Low Report

VolitionRx (NYSE:VNRX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $5.00 price target on the stock.

Report

Date

Time

Symbol

Company Name

Action

%Chg

11/13/2025

04:18 pm

vnrx

volitionrx limited

MISS Report

-4.9%

volitionrx limited

Report

8/14/2025

04:54 pm

vnrx

volitionrx limited

MISS Report

8.1%

volitionrx limited

Report

5/15/2025

05:27 pm

vnrx

volitionrx limited

IN-LINE Report

-8.5%

volitionrx limited

Report

Date

Time

Action

From

Firm

Impact

%Chg

12/3

02:19 pm

Reiterates

Buy

Hold

Maxim Group

Low

Report

1.9%

Report

12/3

02:06 pm

Downgrades

Buy

Hold

Maxim Group

Low

Report

2.5%

Report

12/3

07:56 am

Downgrades

BUY

HOLD

MAXIM

Medium

Report

-4.8%

Report

9/30

08:06 am

Reiterates

Buy

HC Wainwright

Medium

Report

6.7%

Report

Date

Time

Symbol

Headline

Impact

12/11

05:00 pm

vnrx

Form 8-K VOLITIONRX LTD For: Dec 05

Medium Report

Form 8-K VOLITIONRX LTD For: Dec 05

Report

11/17

01:12 pm

vnrx

Form 4 VOLITIONRX LTD For: Nov 17 Filed by: Reynolds Cameron John

Low Report

Form 4 VOLITIONRX LTD For: Nov 17 Filed by: Reynolds Cameron John

Report

11/14

06:29 pm

vnrx

Form SCHEDULE 13G/A VOLITIONRX LTD Filed by: ARMISTICE CAPITAL, LLC

Medium Report

Form SCHEDULE 13G/A VOLITIONRX LTD Filed by: ARMISTICE CAPITAL, LLC

Report

11/10

05:05 pm

vnrx

Form 8-K/A VOLITIONRX LTD For: Nov 07

Medium Report

Form 8-K/A VOLITIONRX LTD For: Nov 07

Report

11/7

05:30 pm

vnrx

Form 8-K VOLITIONRX LTD For: Nov 07

Low Report

Form 8-K VOLITIONRX LTD For: Nov 07

Report

11/4

04:02 pm

vnrx

Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Plummer Nicholas

Medium Report

Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Plummer Nicholas

Report

11/4

04:02 pm

vnrx

Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Retter Andrew

Medium Report

Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Retter Andrew

Report

11/4

04:01 pm

vnrx

Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Butera Salvatore Thomas

Medium Report

Form 4 VOLITIONRX LTD For: Nov 01 Filed by: Butera Salvatore Thomas

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.